Moshe Rogosnitzky

1.7k total citations · 1 hit paper
32 papers, 1.3k citations indexed

About

Moshe Rogosnitzky is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Moshe Rogosnitzky has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Moshe Rogosnitzky's work include Colorectal Cancer Surgical Treatments (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Hemostasis and retained surgical items (2 papers). Moshe Rogosnitzky is often cited by papers focused on Colorectal Cancer Surgical Treatments (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Hemostasis and retained surgical items (2 papers). Moshe Rogosnitzky collaborates with scholars based in United States, France and Israel. Moshe Rogosnitzky's co-authors include Stacy Branch, Ian S. Zagon, Paul Okediji, Igor Koman, Patricia J. McLaughlin, Eléna Kardash, Philippe Zerbib, Sandra I. Bingaman, David T. Mauger and Jill P. Smith and has published in prestigious journals such as Annals of Surgery, The American Journal of Gastroenterology and Experimental Biology and Medicine.

In The Last Decade

Moshe Rogosnitzky

32 papers receiving 1.3k citations

Hit Papers

Gadolinium-based contrast agent toxicity: a review of kno... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers

Moshe Rogosnitzky
Moshe Rogosnitzky
Citations per year, relative to Moshe Rogosnitzky Moshe Rogosnitzky (= 1×) peers Juan Carlos Cutrìn

Countries citing papers authored by Moshe Rogosnitzky

Since Specialization
Citations

This map shows the geographic impact of Moshe Rogosnitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Rogosnitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Rogosnitzky more than expected).

Fields of papers citing papers by Moshe Rogosnitzky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Rogosnitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Rogosnitzky. The network helps show where Moshe Rogosnitzky may publish in the future.

Co-authorship network of co-authors of Moshe Rogosnitzky

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Rogosnitzky. A scholar is included among the top collaborators of Moshe Rogosnitzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Rogosnitzky. Moshe Rogosnitzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amrani, Mehdi El, Guillaume Clément, Xavier Lenne, et al.. (2021). Failure to rescue following proctectomy for rectal cancer: the additional benefit of laparoscopic approach in a nationwide observational study of 44,536 patients. Surgical Endoscopy. 36(1). 435–445. 1 indexed citations
2.
Zerbib, Philippe, Moshe Rogosnitzky, Léonardo Magro, et al.. (2021). Diverting Enterostomy Improves Overall Survival of Patients With Severe Steroid-refractory Gastrointestinal Acute Graft-Versus-Host Disease. Annals of Surgery. 274(5). 773–779. 2 indexed citations
3.
Rogosnitzky, Moshe, Paul Okediji, & Igor Koman. (2020). Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacological Reports. 72(6). 1509–1516. 84 indexed citations
4.
Rogosnitzky, Moshe, et al.. (2020). No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19. JMIRx Med. 1(1). e19583–e19583. 7 indexed citations
5.
Rogosnitzky, Moshe, et al.. (2020). Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point. JMIR Public Health and Surveillance. 6(2). e19199–e19199. 30 indexed citations
7.
Chau, Amélie, Hélène Sarter, Corinne Gower‐Rousseau, et al.. (2017). Persistent perineal sinus after abdominoperineal resection. Langenbeck s Archives of Surgery. 402(7). 1063–1069. 5 indexed citations
8.
Terriou, Louis, Alain Duhamel, David Launay, et al.. (2016). Reemergence of Splenectomy for ITP Second-line Treatment?. Annals of Surgery. 264(5). 772–777. 18 indexed citations
9.
Rogosnitzky, Moshe & Stacy Branch. (2016). Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. BioMetals. 29(3). 365–376. 570 indexed citations breakdown →
10.
Rogosnitzky, Moshe, et al.. (2015). Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration. Journal of Ocular Pharmacology and Therapeutics. 32(2). 83–89. 4 indexed citations
11.
Séguy, D., et al.. (2015). Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome. Langenbeck s Archives of Surgery. 401(1). 81–87. 10 indexed citations
12.
Bienstock, Carol A., et al.. (2014). Pterygium: Nonsurgical Treatment Using Topical Dipyridamole - A Case Report. Case Reports in Ophthalmology. 5(1). 98–103. 7 indexed citations
13.
Bauters, Anne, Moshe Rogosnitzky, É. Hachulla, et al.. (2014). Elevated Plasma Fibrinogen in Clinically Asymptomatic Unicentric Castleman's Disease: A Case Report. Journal of Clinical and Experimental Hematopathology. 54(1). 85–88. 1 indexed citations
14.
Dalgleish, Angus, Peter J Featherstone, Valentin V. Vlassov, & Moshe Rogosnitzky. (2014). Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature. Investigational New Drugs. 32(5). 1048–1052. 12 indexed citations
15.
Zerbib, Philippe, Robert Caïazzo, Guillaume Piessen, et al.. (2013). Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects: a prospective study. Hernia. 19(2). 253–257. 20 indexed citations
16.
Rogosnitzky, Moshe, et al.. (2013). Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis. Techniques in Coloproctology. 18(4). 355–360. 11 indexed citations
17.
Rogosnitzky, Moshe, Milton J. Finegold, Patricia J. McLaughlin, & Ian S. Zagon. (2012). Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment. Investigational New Drugs. 31(4). 1066–1070. 24 indexed citations
18.
Rogosnitzky, Moshe, et al.. (2012). Intravenous immunoglobulin for the treatment of Crohn's disease. Autoimmunity Reviews. 12(2). 275–280. 29 indexed citations
19.
Rogosnitzky, Moshe, et al.. (2011). Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Pharmacological Reports. 63(2). 337–347. 96 indexed citations
20.
Smith, Jill P., et al.. (2007). Low-Dose Naltrexone Therapy Improves Active Crohn's Disease. The American Journal of Gastroenterology. 102(4). 820–828. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026